SBRA Stock Analysis: Buy, Sell, or Hold?
SBRA - Sabra Healthcare REIT, Inc.
$21.17
-0.15 (-0.70%)
▼
5d:
-5.32%
30d:
+7.57%
90d:
+2.47%
HOLD
LOW Confidence
Analysis Updated: Jul 31, 2026 12:00 AM ET
Earnings: Aug 03, 2026
TODAY
Get Alerted When SBRA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: SBRA shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: SBRA shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$29.35
Based on 9.2% avg growth
INTRINSIC VALUE TODAY
$18.23
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: SBRA is currently trading at $21.17, which is considered slightly high relative to its 30-day fair value range of $19.17 to $21.52. The stock's valuation (Forward PE: 27.9) is in line with its historical norms (26.0). At these levels, the market is pricing in 2.4% annual earnings growth.
Technical Outlook: Technically, SBRA is in a strong uptrend. Immediate support is located at $19.82, while resistance sits at $22.77.
Market Sentiment: SBRA has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, SBRA is in a strong uptrend. Immediate support is located at $19.82, while resistance sits at $22.77.
Market Sentiment: SBRA has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$19.17 -
$21.52
Company Quality Score
57/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
74.8%
All Signals
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($22.71)
- BULLISH: Expecting earnings turnaround to 2.4% growth with 21.7% revenue growth
- CAUTION: Recommendation downgraded due to -5.3% 5-day decline
Trading Range Analysis
30-Day Trading Range
$19.17 -
$21.52
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$19.83
Resistance Level
$22.77
Current Trend
Strong Uptrend
Technical data as of
Jul 31, 2026
Fundamental Context
Forward P/E (Next Year Est.)
27.86
Wall Street Target
$22.71
(+7.3%)
Revenue Growth (YoY)
21.7%
Earnings Growth (YoY)
-5.6%
Profit Margin
19.1%
Valuation Premium vs History
+2.4% premium
PE vs Historical
27.9 vs 26.0
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+2.4%
(market-implied from PE analysis)
1-Year Target
$21.68
(+2%)
2-Year Target
$22.20
(+5%)
3-Year Target
$22.73
(+7%)
3-Yr Target (if PE normalizes)
(PE: 28→26)
PE COMPRESSION
$21.22
(+0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 27.9, Growth: 14.3%)
$31.60
(+49%)
Base:
(SPY PE: 20.7, Growth: 14.3%)
$23.52
(+11%)
Bear:
(PE: 17.6, Growth: 14.3%)
$19.99
(-6%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (35x PE), but valuation improves significantly next year (28x PE) as earnings recover.
Trailing PE: 34.95 | Current EPS (TTM): $0.61
Bull Case
$29.22
(+38%)
Analyst growth 24.6%, PE expands to 38.5
Base Case
$26.56
(+26%)
Market implied 24.6%, PE stable at 35.0
Bear Case
$14.50
(-32%)
Severe decline -20.0%, PE contracts to 29.7
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: August 02, 2026 11:50 AM ET
Data refreshes hourly during market hours. Next update: 12:50 PM
Data refreshes hourly during market hours. Next update: 12:50 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SBRA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated REIT - Healthcare Facilities Stocks
Top-rated stocks in REIT - Healthcare Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VTR
Ventas Inc |
STRONG BUY
20 analysts |
$100 | 57 HOLD |
|
WELL
Welltower Inc |
STRONG BUY
20 analysts |
$252 | 60 HOLD |
|
DOC
Healthpeak Properties Inc |
STRONG BUY
20 analysts |
$22 | 44 HOLD |
|
STRW
Strawberry Fields REIT L… |
STRONG BUY
7 analysts |
$15 | 56 HOLD |
|
AHR
American Healthcare REIT… |
STRONG BUY
9 analysts |
$60 | 52 HOLD |
